Evaluation of dyspnea in pregnancy requires knowledge of the normal physiologic changes in pregnancy,
as well as pathologic conditions unique to pregnant women. Evaluation begins with a problem focused history
and physical examination. Any warranted diagnostic studies should be performed without delay, because
poor maternal and fetal outcomes are linked. Treatment of common problems such as asthma, venous
thromboembolism, pneumonia, and other causes of respiratory compromise involve quick and concise
evaluation and therapy geared toward maternal and fetal safety. Food and Drug Administration guidelines
should be followed regarding pharmacologic therapies. Key words: asthma, dyspnea, pneumonia, pregnancy,
thromboembolic disease